Latest filing intelligence
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Read the latest VRTX filing as a structured brief: high-signal changes, financial snapshot, and direct links back to the official SEC source.
AI filing summary
VERTEX PHARMACEUTICALS INC / MA latest filing summary
The filing reads constructive based on revenue and statement momentum.
The latest 10-K for VRTX shows revenue was $12.0B and net income was $4.0B.
Key changes
What stands out in the latest report
- Revenue moved to $12.0B from $11.0B (+8.9% vs prior).
- Net income moved to $4.0B from -$535.6M (+838.1% vs prior).
- Diluted EPS moved to $15.32 from $-2.08 (+836.5% vs prior).
Current read
Positive read
Financial snapshot
Latest reported figures
Trend section
Recent revenue trend
Trend section
Recent EPS trend
Related links
Move through the research workflow
Related companies